Broward Health and Voluntis launch a new clinical evaluation program on digital therapeutics for metastatic breast cancer
Voluntis, a leader in digital therapeutics, announced today a collaboration with Broward Health, a public health system in the U.S. The partnership will focus on conducting a real-world evaluation of Oleena, a digital application that assists patients in managing their symptoms. As part of the collaboration, Oleena, a FDA-authorized digital therapeutic application developed by Voluntis for patients with cancer, will be provided to patients with HR+/HER2- metastatic breast cancer to support them in self-managing symptoms and side effects of their conditions and treatments
#institution
#dtx
#rwe